跳至主要内容
临床试验/NL-OMON19926
NL-OMON19926已完成不适用

Safety and Feasibility of End-ischemic Hypothermic Oxygenated Perfusion of Liver Grafts Donated after Circulatory Death in Liver Transplantation

niversity Medical Center GroningenHanzeplein 1P.O. Box 30.0019700 RB GroningenThe Netherlands0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult patients (> 18 years old) awaiting a liver transplantation and who have been allocated a liver graft from a DCD (Maastricht type 3) donor with a body weight of > 40 kg

排除标准

  • Patients with mental conditions rendering then incapable to understand the nature, scope and consequences of the trial; listed as high urgency; positive test for HIV; pregnant or nursing; donor positive for hepatitis B or C; expected cold ischemia time of > 8 hours

研究者

发起方
niversity Medical Center GroningenHanzeplein 1P.O. Box 30.0019700 RB GroningenThe Netherlands

相似试验